EXPD vs. WST
Compare and contrast key facts about Expeditors International of Washington, Inc. (EXPD) and West Pharmaceutical Services, Inc. (WST).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EXPD or WST.
Correlation
The correlation between EXPD and WST is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
EXPD vs. WST - Performance Comparison
Loading data...
Key characteristics
EXPD:
0.07
WST:
-0.71
EXPD:
0.28
WST:
-0.67
EXPD:
1.04
WST:
0.87
EXPD:
0.09
WST:
-0.65
EXPD:
0.20
WST:
-1.75
EXPD:
9.76%
WST:
22.17%
EXPD:
25.80%
WST:
54.91%
EXPD:
-58.07%
WST:
-59.29%
EXPD:
-9.55%
WST:
-53.63%
Fundamentals
EXPD:
$16.21B
WST:
$15.56B
EXPD:
$6.01
WST:
$6.36
EXPD:
19.69
WST:
34.06
EXPD:
4.15
WST:
3.54
EXPD:
1.47
WST:
5.37
EXPD:
6.89
WST:
5.64
EXPD:
$11.06B
WST:
$2.90B
EXPD:
$1.42B
WST:
$1.00B
EXPD:
$1.15B
WST:
$729.50M
Returns By Period
In the year-to-date period, EXPD achieves a 6.82% return, which is significantly higher than WST's -33.76% return. Over the past 10 years, EXPD has underperformed WST with an annualized return of 11.07%, while WST has yielded a comparatively higher 15.26% annualized return.
EXPD
6.82%
10.90%
-0.93%
1.58%
11.25%
11.07%
WST
-33.76%
7.41%
-31.00%
-38.91%
0.08%
15.26%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
EXPD vs. WST — Risk-Adjusted Performance Rank
EXPD
WST
EXPD vs. WST - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Expeditors International of Washington, Inc. (EXPD) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
EXPD vs. WST - Dividend Comparison
EXPD's dividend yield for the trailing twelve months is around 1.23%, more than WST's 0.38% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EXPD Expeditors International of Washington, Inc. | 1.23% | 1.32% | 1.08% | 1.29% | 0.86% | 1.09% | 1.28% | 1.32% | 1.30% | 1.51% | 1.60% | 1.43% |
WST West Pharmaceutical Services, Inc. | 0.38% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% |
Drawdowns
EXPD vs. WST - Drawdown Comparison
The maximum EXPD drawdown since its inception was -58.07%, roughly equal to the maximum WST drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for EXPD and WST. For additional features, visit the drawdowns tool.
Loading data...
Volatility
EXPD vs. WST - Volatility Comparison
Expeditors International of Washington, Inc. (EXPD) and West Pharmaceutical Services, Inc. (WST) have volatilities of 10.91% and 11.24%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
EXPD vs. WST - Financials Comparison
This section allows you to compare key financial metrics between Expeditors International of Washington, Inc. and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EXPD vs. WST - Profitability Comparison
EXPD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Expeditors International of Washington, Inc. reported a gross profit of 352.86M and revenue of 2.67B. Therefore, the gross margin over that period was 13.2%.
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a gross profit of 231.90M and revenue of 698.00M. Therefore, the gross margin over that period was 33.2%.
EXPD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Expeditors International of Washington, Inc. reported an operating income of 265.86M and revenue of 2.67B, resulting in an operating margin of 10.0%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported an operating income of 107.00M and revenue of 698.00M, resulting in an operating margin of 15.3%.
EXPD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Expeditors International of Washington, Inc. reported a net income of 203.80M and revenue of 2.67B, resulting in a net margin of 7.6%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a net income of 89.80M and revenue of 698.00M, resulting in a net margin of 12.9%.